The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions

Jessica R. Galloway-Peña; Dimitrios P. Kontoyiannis

doi:10.1371/journal.ppat.1008353

Loading metrics

Open Access

Pearls provide concise, practical and educational insights into topics that span the pathogens field.

See all article types »

The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions

Jessica R. Galloway-Peña ,

* E-mail: jrgalloway@mdanderson.org (JRG-P); dkontoyi@mdanderson.org (DPK)

Affiliations Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

http://orcid.org/0000-0003-1081-254X

⨯
Dimitrios P. Kontoyiannis

* E-mail: jrgalloway@mdanderson.org (JRG-P); dkontoyi@mdanderson.org (DPK)

Affiliation Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯

The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions

Jessica R. Galloway-Peña,
Dimitrios P. Kontoyiannis

Published: April 2, 2020
https://doi.org/10.1371/journal.ppat.1008353

About the Authors

Jessica R. Galloway-Peña

* E-mail: jrgalloway@mdanderson.org (JRG-P); dkontoyi@mdanderson.org (DPK)

Affiliations Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

http://orcid.org/0000-0003-1081-254X

Dimitrios P. Kontoyiannis

* E-mail: jrgalloway@mdanderson.org (JRG-P); dkontoyi@mdanderson.org (DPK)

Affiliation Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Competing Interests

The authors have declared that no competing interests exist

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Candida albicans
Is the Subject Area "Candida albicans" applicable to this article?

Thanks for your feedback.
Fungi
Is the Subject Area "Fungi" applicable to this article?

Thanks for your feedback.
Gut bacteria
Is the Subject Area "Gut bacteria" applicable to this article?

Thanks for your feedback.
Gastrointestinal cancers
Is the Subject Area "Gastrointestinal cancers" applicable to this article?

Thanks for your feedback.
Fungal pathogens
Is the Subject Area "Fungal pathogens" applicable to this article?

Thanks for your feedback.
Microbiome
Is the Subject Area "Microbiome" applicable to this article?

Thanks for your feedback.
Clostridium difficile
Is the Subject Area "Clostridium difficile" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.